Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · InnovAge Holding Corp. (INNV)

InnovAge Q1 revenue rises 12.1% to $264.8 million; net income attributable $19.6 million

Positive Impact 3 of 5 earnings Written later

InnovAge reported fiscal first-quarter 2027 results for the period ended September 30, 2026, with total revenues of $264.8 million, up 12.1% from $236.1 million a year earlier. Net income attributable to InnovAge was $19.6 million, or $0.14 per share, compared with $8.0 million, or $0.06 per share, a year earlier. The company confirmed its full fiscal 2027 guidance, which calls for total revenues of $1,050 million to $1,085 million and Adjusted EBITDA of $105 million to $115 million.

Key points

  • Total revenues of $264.8 million, up 12.1% from $236.1 million in the prior-year quarter
  • Net income attributable to InnovAge of $19.6 million, or $0.14 per share, versus $8.0 million, or $0.06 per share
  • Adjusted EBITDA of $31.3 million, up from $17.6 million, with an 11.8% margin
  • Fiscal 2027 guidance confirmed: total revenues of $1,050 million to $1,085 million and Adjusted EBITDA of $105 million to $115 million

The filing

CompanyInnovAge Holding Corp. (INNV)
Form8-K, current report
Filed with the SECNov 3, 2026, 4:07 PM ET
Accession number0001834376-26-000052

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:44 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 03, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.